Moorfields Eye Hospital and SalutarisMD To Collaborate on Treatment for Wet AMD

 

Moorfields Eye Hospital will collaborate with Salutaris Medical Devices (SalutarisMD) to advance the research and development of a novel medical device for use in the treatment of wet AMD, according to a news release. The device reportedly allows the application of brachytherapy through the posterior sclera, avoiding the need for more invasive surgery or complex therapeutic machines.

A Moorfields research team led by Adnan Tufail, MD, FRCOphth; Praveen Patel, MB, BChir, MA, FRCOphth, MD(Res); and Kam Balaggan BSc (Hons), MBBS, MRCOphth, PhD, will work with SalutarisMD on the development, application, and evaluation of this new technology. The device enables lesion-specific targeting, in which the retina specialist delivers localized tissue irradiation that is customized for each patient. It is designed as a clinic-based procedure that can be performed in the same environment as anti-VEGF injections for wet AMD.

The device has been tested in a phase 1 safety trial in the United States. The trial sample was small in size with a short follow-up period; however, the 6 patients enrolled showed improvement in vision, and 3 patients required no additional anti-VEGF injections within the 90-day trial period.

“One of the attractions of this application is the way it enables the treatment to be administered in a noninvasive way, without the need for complex expensive equipment,” Peng Khaw, Director of Research and Development at Moorfields Eye Hospital, said in the news release.

 

Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

Karen Roman
Editor-in-Chief
484-581-1827
kroman@bmctoday.com

Janet Burk
Publisher
214-394-3551
jburk@bmctoday.com

About Retina Today

Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.